Frank Morich - 27 May 2022 Form 4 Insider Report for Cue Biopharma, Inc. (CUE)

Role
Director
Signature
/s/ Frank Morich by Colin Sandercock, attorney-in-fact
Issuer symbol
CUE
Transactions as of
27 May 2022
Net transactions value
+$105,000
Form type
4
Filing time
31 May 2022, 16:06:33 UTC
Previous filing
05 Jan 2022
Next filing
05 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CUE Common Stock Purchase $105,000 +28,000 $3.75 28,000 27 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.